Fluorescent markers for hypoxic cells: A study of novel heterocyclic compounds that undergo bio-reductive binding
- 15 February 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (4) , 533-541
- https://doi.org/10.1016/0006-2952(91)90625-f
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxiaInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Covalent binding of a fluorinated 2-nitroimidazole to emt-6 tumors in Balb/C mice: detection by f-19 nuclear magnetic resonance at 2.35 TInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: Evidence that a side-chain label is bound as efficiently as a ring labelBritish Journal of Cancer, 1985
- Binding of 14C-misonidazole to hypoxic cells in V79 spheroidsBritish Journal of Cancer, 1982
- Intracapillary oxyhemoglobin saturation of malignant tumors in humansInternational Journal of Radiation Oncology*Biology*Physics, 1981
- A marker for hypoxic cells in tumours with potential clinical applicabilityBritish Journal of Cancer, 1981
- Hyperbaric oxygen: the Medical Research Council trials and their clinical significanceThe British Journal of Radiology, 1978
- Oxygen inhibition of nitroreductase: Electron transfer from nitro radical-anions to oxygenBiochemical and Biophysical Research Communications, 1976
- The role of catalytic superoxide formation in the O2 inhibition of nitroreductaseBiochemical and Biophysical Research Communications, 1975
- The Histological Structure of Some Human Lung Cancers and the Possible Implications for RadiotherapyBritish Journal of Cancer, 1955